MEDI 23-Multivalent muscarinic antagonists for the treatment of overactive bladder (OAB)

被引：0

作者：

Hughes, Adam D. ^{[1
]}

Chin, Kay H. ^{[2
]}

Hegde, Sharath S. ^{[3
]}

Husfeld, Craig O. ^{[1
]}

Jasper, Jeffrey R. ^{[2
]}

Ji, Yuhua ^{[1
]}

King, Kristin E. ^{[2
]}

Lee, Tae Weon ^{[2
]}

Li, Li ^{[1
]}

Mammen, Mathai ^{[2
]}

McNamara, Alexander J. ^{[3
]}

Mischki, Trevor K. ^{[1
]}

Obedencio, Glenmar P. ^{[3
]}

Pulido-Rios, Tess ^{[3
]}

Steinfeld, Tod ^{[2
]}

Sweazey, Shelley M. ^{[3
]}

Wilson, Richard D. ^{[1
]}

机构：

[1] Theravance Inc, Med Chem, San Francisco, CA 94080 USA

[2] Theravance Inc, Mol & Cellular Biol, San Francisco, CA 94080 USA

[3] Theravance Inc, Pharmacol, San Francisco, CA 94080 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

23-MEDI

引用

页数：1

共 50 条

[11] A NOVEL BLADDER INJECTION SYSTEM USED FOR ONABOTULINUMTOXNA TREATMENT OF OVERACTIVE BLADDER (OAB)
Smith, J. J., III
Proctor, J.
MacDiarmid, S.
Jacobs, B. E.
Green, L. S.
Gwynn, E. S.
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S328 - S328
[12] Do continent patients with overactive bladder respond to muscarinic receptor antagonists?
Rovner, ES
NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (10): : 472 - 473
[13] Muscarinic Receptor Antagonists, the Overactive Bladder and Efficacy against Urinary Urgency
Mansfield, Kylie J.
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 471 - 480
[14] Do continent patients with overactive bladder respond to muscarinic receptor antagonists?
Eric S Rovner
Nature Clinical Practice Urology, 2005, 2 : 472 - 473
[15] WEARABLE NEUROMODULATION SYSTEM FOR OVERACTIVE BLADDER (OAB): A PREFERRED TREATMENT OPTION
Ganesan, Mohanraj
Tarver, Monica L.
NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S155 - S156
[16] Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)
Jankiewicz, Katarzyna
Kulik-Rechberger, Beata
Nowakowski, Lukasz
Rechberger, Tomasz
GINEKOLOGIA POLSKA, 2012, 83 (07) : 532 - 536
[17] PERCUTANEOUS TIBIAL NERVE STIMULATION FOR THE TREATMENT OF OVERACTIVE BLADDER (OAB): OUR EXPERIENCE
Bardelli, Irene
Pistolesi, Donatella
Mariani, Chiara
Santarsieri, Michele
Selli, Cesare
NEUROUROLOGY AND URODYNAMICS, 2013, 32 : S29 - S30
[18] DEVELOPMENT OF A PATIENT SATISFACTION WITH TREATMENT QUESTIONNAIRE FOR OVERACTIVE BLADDER (OAB-PSTQ)
Barron, Richard L.
Sissins, Peter
QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 2144 - 2144
[19] Persistence in the treatment of overactive bladder syndrome (OAB) with mirabegron in a multicenter clinical study
Martan, Alois
Masata, Jaromir
Krhut, Jan
Zachoval, Roman
Hanus, Tomas
Svabik, Kamil
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 210 : 247 - 250
[20] PFIZER Muscarinic receptor antagonist approved for the treatment of overactive bladder
不详
FORMULARY, 2008, 43 (12) : 434 - 435

← 1 2 3 4 5 →